DIASORIN Financial Statements From 2010 to 2024
| 34D Stock | EUR 101.15 1.25 1.22% |
Check DIASORIN financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DIASORIN's main balance sheet or income statement drivers, such as , as well as many indicators such as . DIASORIN financial statements analysis is a perfect complement when working with DIASORIN Valuation or Volatility modules.
DIASORIN |
DIASORIN Company EBITDA Analysis
DIASORIN's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current DIASORIN EBITDA | 517.3 M |
Most of DIASORIN's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DIASORIN is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, DIASORIN reported earnings before interest,tax, depreciation and amortization of 517.3 M. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The ebitda for all Germany stocks is notably lower than that of the firm.
DIASORIN Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DIASORIN's current stock value. Our valuation model uses many indicators to compare DIASORIN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DIASORIN competition to find correlations between indicators driving DIASORIN's intrinsic value. More Info.DIASORIN is the top company in current valuation category among its peers. It is rated second in price to book category among its peers . The ratio of Current Valuation to Price To Book for DIASORIN is about 1,820,870,570 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DIASORIN's earnings, one of the primary drivers of an investment's value.About DIASORIN Financial Statements
DIASORIN stakeholders use historical fundamental indicators, such as DIASORIN's revenue or net income, to determine how well the company is positioned to perform in the future. Although DIASORIN investors may analyze each financial statement separately, they are all interrelated. For example, changes in DIASORIN's assets and liabilities are reflected in the revenues and expenses on DIASORIN's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DIASORIN. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DIASORIN Stock
DIASORIN financial ratios help investors to determine whether DIASORIN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DIASORIN with respect to the benefits of owning DIASORIN security.